The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles